Peptable

Comparison

MGF vs SS-31

Also see:

MGFSS-31

Function

While MGF is upregulated in muscle after mechanical overload, where it supports tissue repair and growth; recombinant forms are studied for regenerative and performance-enhancement effects22138, SS-31 improves mitochondrial bioenergetics, reduces oxidative stress, and shows protective effects in models of ischemia-reperfusion, neurodegeneration, and other mitochondrial disorders4637137.

Mechanism

While MGF works as a 24-amino-acid E-peptide splice variant of IGF-1 (IGF-1Ec) produced in mechanically stressed or damaged muscle that activates IGF1R and local anabolic pathways involved in muscle repair and hypertrophy22138144, SS-31 is a mitochondria-targeted tetrapeptide, d-Arg-dimethylTyr-Lys-Phe-NH2, that selectively binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae structure, improving electron transport, and reducing ROS production4637137143.

Receptor

MGF

Insulin-like growth factor 1 receptor (IGF1R) 134139

SS-31

Cardiolipin-rich inner mitochondrial membrane; interacts with cardiolipin and associated mitochondrial proteins rather than a classical cell-surface receptor46137143

Organism or Origin

MGF

Endogenous human IGF-1 splice variant (IGF-1Ec) 2213897

SS-31

Fully synthetic Szeto–Schiller tetrapeptide; not encoded in the genome4637

Gene

MGF

IGF1

SS-31

Not assigned in the current dataset.

Summary

The clearest overlap between MGF and SS-31 is that both converge around Signaling modulator. Their typical research and application settings separate fairly clearly: MGF is more often discussed in the realm of Musculoskeletal health, whereas SS-31 is more often associated with the realm of Aging and longevity and Cardiovascular health. Both appear to work through Signaling modulator, but the functional emphasis still separates, with MGF leaning toward Anabolic growth and Tissue repair and healing and SS-31 leaning toward Mitochondrial function modulation, Antioxidant activity, and Neuroprotection and cognition. MGF has a more natural endogenous origin, while SS-31 is closer to synthetic design background with MGF in Preclinical development and SS-31 in Clinical phase 2. SS-31 incorporates d-amino acid substitution and amidation features that are not part of MGF, while their sequence patterns also diverge, with MGF showing protein-mimetic sequence features and SS-31 showing cationic amphipathic features.

Related articles

No related articles are linked to these peptides yet.

Sources

22Mechano growth factor - Wikipedia, https://en.wikipedia.org/wiki/Mechano_growth_factor
97IGF1 Gene - Insulin Like Growth Factor 1, https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGF1
134Insulin-like growth factor 1 receptor - Wikipedia, https://en.wikipedia.org/wiki/Insulin-like_growth_factor_1_receptor
138A Splice Variant of IGF-1 within the Growth Plate | PLOS One, https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0076133
139IGF1 receptor signaling pathways, https://pubmed.ncbi.nlm.nih.gov/29535161/
144Insulin-like growth factor 1 - Wikipedia, https://en.wikipedia.org/wiki/Insulin-like_growth_factor_1
46Discovery of novel SS-31 (d-Arg-dimethylTyr-Lys-Phe-NH2 ... - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC11409442/
56Discovery of novel SS-31 (d-Arg-dimethylTyr-Lys-Phe-NH2 ..., https://pubs.rsc.org/en/content/articlelanding/2024/ra/d4ra05517a
137Mitochondrial protein interaction landscape of SS-31 | PNAS, https://www.pnas.org/doi/10.1073/pnas.2002250117
143SS-31 Peptide: Mitochondrial Repair for Energy and Longevity, https://revolutionhealth.org/blogs/news/peptide-therapy-ss-31